Eli Lilly (LLY) Treasury Shares (2009 - 2026)

Eli Lilly (LLY) has reported Treasury Shares for 18 consecutive years, with $3.0 billion the latest figure, recorded in Q1 2026.

• Treasury Shares for Q1 2026 came in at $3.0 billion, up 5986.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.0 billion (up 5986.87% YoY), and the FY2025 annual result was $3.0 billion, changed 0.0% from the prior year.
• Treasury Shares was $3.0 billion for Q1 2026 at Eli Lilly, roughly flat from $3.0 billion in the prior quarter.
• Over five years, Treasury Shares peaked at $50.0 million in Q4 2024 and troughed at -$2.5 million in Q3 2021.
• Average Treasury Shares over 5 years is $6.0 million, with a median of $450000.0 recorded in 2022.
• Year-over-year, Treasury Shares plunged 98.91% in 2024 and surged 9114.68% in 2025.
• Over 5 years, Treasury Shares stood at $3.0 billion in 2022, then plunged by 98.53% to $44.2 million in 2023, then jumped by 6716.74% to $3.0 billion in 2024, then changed by 0.0% to $3.0 billion in 2025, then changed by 0.0% to $3.0 billion in 2026.
• Per Business Quant data, the three most recent Treasury Shares figures were $3.0 billion in Q1 2026, $3.0 billion in Q4 2025, and $3.0 billion in Q3 2025.